Free Trial

Sciencast Management LP Trims Position in The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background
Remove Ads

Sciencast Management LP trimmed its stake in The Clorox Company (NYSE:CLX - Free Report) by 36.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,841 shares of the company's stock after selling 2,245 shares during the quarter. Sciencast Management LP's holdings in Clorox were worth $624,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Brooklyn Investment Group boosted its stake in Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC purchased a new position in Clorox in the third quarter worth about $27,000. Continuum Advisory LLC lifted its stake in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after buying an additional 138 shares in the last quarter. Millstone Evans Group LLC bought a new position in shares of Clorox in the fourth quarter worth approximately $31,000. Finally, Asset Planning Inc purchased a new stake in shares of Clorox during the fourth quarter valued at approximately $32,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Performance

Shares of NYSE:CLX traded up $2.72 during trading on Thursday, hitting $145.70. The company's stock had a trading volume of 1,282,431 shares, compared to its average volume of 1,213,119. The company has a 50-day moving average of $151.92 and a 200-day moving average of $159.31. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The firm has a market cap of $17.95 billion, a price-to-earnings ratio of 39.81, a P/E/G ratio of 2.62 and a beta of 0.45. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Remove Ads

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the firm earned $2.16 EPS. On average, sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.35%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio is presently 133.33%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on CLX shares. Evercore ISI boosted their price objective on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Wells Fargo & Company upped their price target on Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Barclays dropped their price objective on Clorox from $140.00 to $139.00 and set an "underweight" rating on the stock in a research report on Thursday. DA Davidson decreased their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, Clorox presently has a consensus rating of "Hold" and a consensus target price of $159.50.

Check Out Our Latest Stock Report on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads